- Home
- RILY vs HLVX Comparison
RILY vs HLVX Comparison
Compare RILY & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILY
- HLVX
- Stock Information
- Founded
- RILY 1973
- HLVX 2020
- Country
- RILY United States
- HLVX United States
- Employees
- RILY N/A
- HLVX N/A
- Industry
- RILY Investment Managers
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- RILY Finance
- HLVX Health Care
- Exchange
- RILY Nasdaq
- HLVX Nasdaq
- Market Cap
- RILY 91.8M
- HLVX 83.7M
- IPO Year
- RILY 2007
- HLVX 2022
- Fundamental
- Price
- RILY $3.25
- HLVX $2.06
- Analyst Decision
- RILY
- HLVX Hold
- Analyst Count
- RILY 0
- HLVX 5
- Target Price
- RILY N/A
- HLVX $2.33
- AVG Volume (30 Days)
- RILY 1.1M
- HLVX 454.3K
- Earning Date
- RILY 08-14-2025
- HLVX 08-07-2025
- Dividend Yield
- RILY N/A
- HLVX N/A
- EPS Growth
- RILY N/A
- HLVX N/A
- EPS
- RILY N/A
- HLVX N/A
- Revenue
- RILY $854,383,000.00
- HLVX N/A
- Revenue This Year
- RILY N/A
- HLVX N/A
- Revenue Next Year
- RILY N/A
- HLVX N/A
- P/E Ratio
- RILY N/A
- HLVX N/A
- Revenue Growth
- RILY N/A
- HLVX N/A
- 52 Week Low
- RILY $2.67
- HLVX $1.34
- 52 Week High
- RILY $20.80
- HLVX $14.43
- Technical
- Relative Strength Index (RSI)
- RILY 63.47
- HLVX 63.20
- Support Level
- RILY $2.90
- HLVX $1.99
- Resistance Level
- RILY $3.25
- HLVX $2.12
- Average True Range (ATR)
- RILY 0.16
- HLVX 0.08
- MACD
- RILY 0.04
- HLVX 0.02
- Stochastic Oscillator
- RILY 89.09
- HLVX 80.33
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.